Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Scoble, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scoble, J. E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2003) 18: 1700-1703
© 2003 European Renal Association-European Dialysis and Transplant Association

Editorial Comment

Do protection devices have a role in renal angioplasty and stent placement?

John E. Scoble

Guys and St Thomas’ Trust, London, UK

Correspondence and offprint requests to: John E. Scoble, Guy’s Hospital, St Thomas Street, London SE1 9RT, UK. Email: john.scoble@gstt.sthames.nhs.uk

Keywords: renal angioplasty; renal atherosclerotic vascular disease; stent placement

The first 10% of the full text of this article appears below.

In renal atherosclerotic vascular disease there is often no firm randomized trial data to guide clinical practice. Nephrologists often have to interpret trial data from other vascular territories. Vascular protection devices are now an issue in the carotid and cardiac territories. Should they have a role in renal atherosclerotic disease?

There is considerable literature on renal atheroembolic disease. The early paper of Thurlbeck and Castleman [1] showed that in post-mortem renal histology analysis after aortic aneurysm repair followed by death there was an incidence of renal atheroembolic disease of >70%. It also showed that there was a >20% incidence of atheroembolic disease in individuals with no intervention but severe aortic atherosclerotic disease. Flory [2] showed that this condition is related to cholesterol crystal embolization to the renal vascular bed and suggested that the vessels occluded were between 55 and 900 µm in diameter. There . . . [Full Text of this Article]

Embolization at angioplasty?

Embolization and type of procedure

Stent protection

Conclusion and perspective


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CirculationHome page
C. J. White
Catheter-Based Therapy for Atherosclerotic Renal Artery Stenosis
Circulation, March 21, 2006; 113(11): 1464 - 1473.
[Full Text] [PDF]